Portfolio map · VC firm · Hong Kong SAR China
Lilly Asia Ventures portfolio map
63 startups Lilly Asia Ventures has backed in rounds we track, since 2012, grouped by their main sector. Together they have raised $9.5B. The biggest sector is Biotech, with 52 companies.
Biotech
52
Structure Therapeutics
Terns Pharmaceuticals
Verdiva Bio
Legend Biotech- TPTurning Point Therapeutics
- IMInsilico Medicine
Innovent Biologics
Passage BioAlumis
ArriVent- CPCinCor Pharma
InventisBio
Alector
Metacrine
KSQ Therapeutics- IInnovent
- HTHarpoon Therapeutics
- TTmunity
- TTTP Therapeutics
- BRBurning Rock
Synnovation Therapeutics
OTR Therapeutics
Singleron Biotechnologies
Synthekine
+28 more
Funding by segment
- Biotech$8.4B52
- Pharma$726M6
- Healthtech$352M5
Where they are based
- United States34$5.8B
- China15$1.4B
- Hong Kong SAR China3$611M
- Singapore2$125M
- United Kingdom1$601M
- Japan1$87M
United States
China
Hong Kong SAR China
Singapore
United Kingdom
JapanFounded
14 without a founding year on record.
Total raised
- Under $1M1
- $1M to $10M1
- $10M to $50M12
- $50M to $250M37
- $250M to $1B12
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
49 of 63 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States34
- China15
- Hong Kong SAR China3
- Singapore2
- United Kingdom1
- Japan1
Startups by country, 6 countries in all.
Segment by segment
Biotech
52 startups · $8.4B raised
- Structure TherapeuticsStructure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.United States$748M
- Terns PharmaceuticalsTerns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden.United States$730M
- Verdiva BioVerdiva Bio is a clinical-stage biopharmaceutical company based in Guildford, United Kingdom, founded in 2024.United Kingdom$601M
- Legend BiotechLegend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.United States$576M
- TPTurning Point TherapeuticsTurning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.-$460M
- IMInsilico MedicineHong Kong SAR China$392M
- Innovent BiologicsEstablished in 2011, Innovent is committed to developing, manufacturing and commercializing high quality innovative medicines for China$385M
- Passage BioPassage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.United States$380M
Pharma
6 startups · $726M raised
- IInhibrxUnited States$265M
Timberlyne TherapeuticsTimberlyne Therapeutics is a clinical-stage biopharmaceutical company based in San Diego, California, founded in 2024.United States$180M
Elpiscience BiopharmaceuticalsElpiscience Biopharmaceuticals is a clinical-stage biopharmaceutical company based in Shanghai, China, founded in 2017.China$105M
Comanche BiopharmaComanche Biopharma Corp.United States$75M
Precede BiosciencesPrecede Biosciences is a Boston-based precision diagnostics and data company founded in 2021.United States$64M
Caldera TherapeuticsCaldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).United States$38M
Healthtech
5 startups · $352M raised
- PMPeijia MedicalPeijia Medical is an interventional medical products provider-$100M
Virtue DiagnosticsVirtue Diagnostics is a global in vitro diagnostics (IVD) company founded in 2019, with a focus on providing affordable and precisSingapore$100M- SSingleraChina$74M
Akura MedicalTecnología e innovación para profesionales de la odontología.United States$53M- GMGenesis MedtechGenesis Medtech is a medical device company.Singapore$25M
How this map is made. Every startup here has raised money in a round we track that names Lilly Asia Ventures as an investor, the first in 2012. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Lilly Asia Ventures?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.